XML 47 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Industry Segment and Geographic Area Information
 12 Months Ended
Jan. 03, 2021
Segment Reporting [Abstract]  
Industry Segment Information Industry Segment and Geographic Area Information
The Company discloses information about its operating segments based on the way that management organizes the segments within the Company for making operating decisions and assessing financial performance. The Company evaluates the performance of its operating segments based on revenue and operating income. Intersegment revenue and transfers are not significant. The accounting policies of the operating segments are the same as those described in Note 1.
The principal products and services of the Company's two operating segments are:
•Discovery & Analytical Solutions. Provides products and services targeted towards the life sciences and applied markets.
•Diagnostics. Develops diagnostics, tools and applications focused on clinically-oriented customers, especially within the reproductive health, emerging market diagnostics and applied genomics markets. The Diagnostics segment serves the diagnostics market.
The Company has included the expenses for its corporate headquarters, such as legal, tax, audit, human resources, information technology, and other management and compliance costs, as well as the activity related to the mark-to-market adjustment on postretirement benefit plans, as “Corporate” below. The Company has a process to allocate and recharge expenses to the reportable segments when these costs are administered or paid by the corporate headquarters based on the extent to which the segment benefited from the expenses. These amounts have been calculated in a consistent manner and are included in the Company’s calculations of segment results to internally plan and assess the performance of each segment for all purposes, including determining the compensation of the business leaders for each of the Company’s operating segments.
Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below for the fiscal years ended:
 
January 3,
2021		December 29,
2019		December 30,
2018
 (In thousands)
Discovery & Analytical Solutions
Product revenue$995,216 $1,054,862 $1,010,899 
Service revenue720,587 691,299 682,312 
Total revenue1,715,803 1,746,161 1,693,211 
Operating income from continuing operations(1)
183,471 238,331 230,481 
Diagnostics
Product revenue1,783,509 962,180 924,594 
Service revenue283,433 175,332 160,191 
Total revenue2,066,942 1,137,512 1,084,785 
Operating income from continuing operations(1)(2)
874,206 189,330 153,196 
Corporate
Operating loss from continuing operations(3)
(79,096)(65,688)(59,793)
Continuing Operations
Product revenue2,778,725 2,017,042 1,935,493 
Service revenue1,004,020 866,631 842,503 
Total revenue3,782,745 2,883,673 2,777,996 
Operating income from continuing operations978,581 361,973 323,884 
Interest and other expense, net (see Note 6)72,217 124,831 66,201 
Income from continuing operations before income taxes$906,364 $237,142 $257,683 
____________________________
(1)Legal costs for significant litigation matters and settlements in the Company's Discovery & Analytical Solutions segment were $5.9 million, $2.2 million and $5.3 million for fiscal years 2020, 2019 and 2018, respectively. Legal costs for significant litigation matters and settlements in the Company's Diagnostics segment were $1.2 million, $0.1 million and $0.2 million for fiscal years 2020, 2019 and 2018, respectively.
(2)Asset impairment in the Company's Diagnostics segment was $7.9 million for fiscal year 2020.
(3)Costs for significant environmental matters was $5.2 million for fiscal year 2020. Stock compensation expense from acceleration of executive compensation was $7.7 million for fiscal year 2019.
Additional information relating to the Company’s reporting segments is as follows for the three fiscal years ended January 3, 2021:
 Depreciation and Amortization ExpenseCapital Expenditures
 January 3,
2021		December 29,
2019		December 30,
2018		January 3,
2021		December 29,
2019		December 30,
2018
 (In thousands)(In thousands)
Discovery & Analytical Solutions$93,516 $74,445 $70,362 $20,217 $27,778 $34,852 
Diagnostics149,738 136,476 107,434 55,236 46,863 54,737 
Corporate3,253 3,104 2,792 2,053 1,690 3,664 
Continuing operations$246,507 $214,025 $180,588 $77,506 $76,331 $93,253 
 Total Assets
 January 3,
2021		December 29,
2019		December 30,
2018
 (In thousands)
Discovery & Analytical Solutions$3,600,860 $3,082,917 $2,567,054 
Diagnostics4,228,943 3,368,598 3,358,964 
Corporate130,512 87,049 49,504 
Total assets$7,960,315 $6,538,564 $5,975,522 
The following geographic area information for continuing operations includes revenue based on location of external customers for the three fiscal years ended January 3, 2021 and net long-lived assets based on physical location as of January 3, 2021 and December 29, 2019:
 Revenue
 January 3,
2021		December 29,
2019		December 30,
2018
 (In thousands)
U.S.$1,269,293 $974,187 $906,398 
International:
China492,283 581,688 559,865 
United Kingdom362,591 70,703 72,124 
Germany200,294 146,577 142,411 
Italy163,056 101,461 95,908 
France148,898 96,994 97,990 
Republic of Korea114,846 71,069 60,126 
India103,785 97,423 92,327 
Japan88,473 82,478 79,238 
Other international839,226 661,093 671,609 
Total international2,513,452 1,909,486 1,871,598 
Total sales$3,782,745 $2,883,673 $2,777,996 
 
 Net Long-Lived Assets*
 January 3,
2021		December 29,
2019		December 30,
2018
 (In thousands)
U.S.$197,755 $269,183 $201,649 
International:
Germany149,105 119,612 99,181 
China75,199 71,216 61,261 
Finland60,559 29,052 16,211 
United Kingdom35,243 51,659 33,429 
Singapore24,291 23,063 14,942 
India21,975 19,691 14,636 
Italy17,051 14,152 11,324 
France13,325 12,940 3,210 
Brazil8,627 9,126 8,237 
Poland7,732 7,216 3,212 
Canada5,671 6,485 5,454 
Other international34,625 26,210 17,565 
Total international453,403 390,422 288,662 
Total net long-lived assets$651,158 $659,605 $490,311 
* Long-lived assets consist of property and equipment, net, operating lease right-of-use assets, rental equipment, software and other long-term assets.